why choose us

First received: September 20, 2022

Clinical Trial: Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Neuromyelitis Optica Spectrum Disorder

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-controlled Phase ? Clinical Study to Evaluate the Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spec

Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled Phase ? study to evaluate the efficacy and safety of Mitoxantrone Hydrochloride Liposome Injection with different doses in participants with neuromyelitis optica spectrum disorder (NMOSD).Participants will be randomly enrolled into three groups: Mitoxantrone Hydrochloride Liposome Injection 8 mg/m^2 group, Mitoxantrone Hydrochloride Liposome Injection 12 mg/m^2 group, and Placebo group.The primary outcome measure is time to first…

Read more